Platelet Rich Plasma for the Treatment of Scarring Alopecia Due to Discoid Lupus Erythematosus.
Study Design
- Tipo de Estudo
- Case Reports
- População
- Patients with scarring alopecia due to DLE
- Intervenção
- Platelet Rich Plasma for the Treatment of Scarring Alopecia Due to Discoid Lupus Erythematosus. None
- Comparador
- None
- Desfecho Primário
- Hair regrowth in scarring alopecia (DLE)
- Direção do Efeito
- Positive
- Risco de Viés
- High
Abstract
Platelet-rich plasma (PRP) is an autologous concentration of plasma from a patient’s blood containing platelets up to 7 times higher than normal plasma. Originally indicated to improve connective tissue regeneration in orthopedic surgery, PRP has also proven to be advantageous in the treatment of androgenic alopecia (AGA), alopecia areata (AA), and other forms of non-scarring alopecia.
Resumo Rápido
Platelet-rich plasma (PRP) is an autologous concentration of plasma from a patient’s blood containing platelets up to 7 times higher than normal plasma, originally indicated to improve connective tissue regeneration in orthopedic surgery, which has also proven to be advantageous in the treatment of androgenic alopecia.
Used In Evidence Reviews
Similar Papers
Journal of cosmetic dermatology · 2021
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Stem cells translational medicine · 2015
The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial.
Clinical reviews in allergy & immunology · 2021
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Cells · 2019
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.
The British journal of dermatology · 2013
A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2018